Biologics Contract Development Market
According to Intent Market Research, the Biologics Contract Development Market is expected to grow from USD 14.7 billion in 2023 at a CAGR of 7.3% to touch USD 24.1 billion by 2030. The Biologics Contract Development Market is dominated by key players such as, Charles River Laboratories, Boehringer Ingelheim, Lonza, Samsung Biologics, Rentschler Biopharma, and Parexel.